BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/3/2026 6:28:03 AM | Browse: 1 | Download: 1
 |
Received |
|
2025-10-17 12:49 |
|
Peer-Review Started |
|
2025-10-17 12:55 |
|
First Decision by Editorial Office Director |
|
2025-10-22 06:43 |
|
Return for Revision |
|
2025-10-22 06:43 |
|
Revised |
|
2025-10-24 15:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-27 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-27 08:24 |
|
Articles in Press |
|
2025-11-27 08:24 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 05:58 |
|
Publish the Manuscript Online |
|
2026-02-03 06:28 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Advancing precision medicine in human epidermal growth factor receptor 2 negative gastric cancer: Insights from a novel nomogram for immunochemotherapy prognosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abinash Nayak, Gunanidhi Sahoo and Sudhansu Sekhar Nishank |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abinash Nayak, Academic Fellow, Assistant Professor, Lecturer, Research Fellow, Researcher, Post-graduate Department of Zoology, Utkal University, Vani Vihar, Bhubaneshwar 751004, Odisha, India. abinashnayakzoology@gmail.com |
| Key Words |
Gastric cancer; Human epidermal growth factor receptor 2; Immunochemotherapy; Nomogram; Prognostic model; Biomarkers; Precision oncology |
| Core Tip |
The nomogram by Yao et al represents a comprehensive tool for prognosticating outcomes in advanced human epidermal growth factor receptor 2-negative gastric cancer patients on immunochemotherapy. By incorporating immune, clinicopathological, and inflammatory markers, it achieves high discriminative power. Recent advancements in circulatory tumor DNA, artificial intelligence-radiomics, and combination therapies like claudin 18.2-targeting complement this model, highlighting the need for prospective validation to enhance clinical utility. |
| Publish Date |
2026-02-03 06:28 |
| Citation |
Nayak A, Sahoo G, Nishank SS. Advancing precision medicine in human epidermal growth factor receptor 2 negative gastric cancer: Insights from a novel nomogram for immunochemotherapy prognosis. World J Gastrointest Oncol 2026; 18(2): 115401 |
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i2/115401.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v18.i2.115401 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
